Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Auxilium Rejects Endo's Takeover Offer

September 22, 2014 8:40 am | News | Comments

Auxilium Pharmaceuticals Inc.'s board has rejected an approximately $1.4 billion unsolicited takeover offer from Ireland's Endo International PLC. Read more...                          

TOPICS:

Germany's Merck to Buy Sigma Aldrich for $17B

September 22, 2014 7:40 am | by David McHugh, AP Business Writer | News | Comments

German drug company Merck says it has agreed to buy St. Louis-based chemical firm Sigma-Aldrich Corp. for $17 billion. Darmstadt-based Merck KGaA said Monday it is paying $140 per share in cash for all of Sigma-Aldrich's share. Read more...

TOPICS:

Soligenix Gets $24.7M for Development of Heat-Stable RiVax Vaccine

September 19, 2014 10:28 am | News | Comments

Soligenix Inc. announced that it has been awarded a contract valued at up to $24.7 million to advance the development of Soligenix’s thermostabilization technology, ThermoVax, combined with the company’s ricin toxin vaccine, RiVax. Read more...  

TOPICS:
Advertisement

Modified Antibiotic Can Vanquish Resistant Bacteria

September 19, 2014 10:23 am | News | Comments

Scientists have devised a new antibiotic based on vancomycin that is powerfully effective against vancomycin-resistant strains of MRSA and other disease-causing bacteria. Read more...                   

TOPICS:

A New Way to Prevent the Spread of Devastating Diseases

September 19, 2014 10:18 am | News | Comments

For decades, researchers have tried to develop broadly effective vaccines to prevent the spread of illnesses such as HIV, malaria, and tuberculosis. While limited progress has been made along these lines, there are still no licensed vaccinations available that can protect against these diseases. Now, researchers are approaching the problem in a different way. Read more...

TOPICS:

Pfizer Provides $2M to Support ‘Last-Mile’ Vaccine Coverage

September 19, 2014 10:04 am | News | Comments

The Pfizer Foundation announced $2 million in grant funding for pilot programs to improve immunization coverage in Africa. Grant recipients include UNICEF, Save the Children and International Rescue Committee. Read more...      

TOPICS:

New Approach to Arthritis Drug Delivery Could Help Avoid Side Effects

September 19, 2014 9:54 am | News | Comments

A new approach to arthritis treatment, which avoids unforeseen side effects by delivering drugs exclusively to affected inflamed joints, has been developed by researchers in London. Read more...                

TOPICS:

Gilead Cancer Drug Approved in Europe

September 19, 2014 9:22 am | News | Comments

Gilead Sciences Inc. announced that the European Commission has granted marketing authorization for Zydelig (idelalisib), a first-in-class oral treatment for chronic lymphocytic leukemia (CLL) and follicular lymphoma (FL). Read more...     

TOPICS:
Advertisement

China Fines GSK $492M for Bribery

September 19, 2014 9:13 am | by Joe McDonald, AP Business Writer | News | Comments

Drug maker GlaxoSmithKline was fined $492 million on Friday for bribing doctors in China in the biggest such penalty ever imposed by a Chinese court. Read more...                         

TOPICS:

Afamelanotide Holds Promise as Vitiligo Treatment

September 19, 2014 8:30 am | Videos | Comments

A treatment regimen is safe and effective for restoring skin pigmentation in vitiligo patients, according to a new study. Read more...                                 

TOPICS:

Why Live Vaccines May be Most Effective for Preventing Salmonella Infection

September 18, 2014 11:20 pm | News | Comments

Vaccines against Salmonella that use a live, but weakened, form of the bacteria are more effective than those that use only dead fragments because of the particular way in which they stimulate the immune system, according to new research. Read more...

TOPICS:

EC Approves Xultophy for Adult Diabetes

September 18, 2014 11:03 pm | News | Comments

Novo Nordisk announced that the European Commission has granted marketing authorization for Xultophy for the treatment of type 2 diabetes mellitus in adults. Read more...                       

TOPICS:

White House Orders Plan for Antibiotic Resistance

September 18, 2014 10:57 pm | News | Comments

Signaling the seriousness of the threat posed by antibiotic-resistant germs, President Barack Obama on Thursday ordered the government to create a national plan to fight them by early 2015. Read more...             

TOPICS:

FDA Approves Eli Lilly's Injectable Diabetes Drug

September 18, 2014 4:41 pm | by The Associated Press | News | Comments

The Food and Drug Administration has approved a new injectable diabetes drug from Eli Lilly and Co. for adults with the most common form of the disease. Read more...                         

TOPICS:

Vaccine Stops Catheter-Linked UTIs in Mice

September 18, 2014 4:13 pm | News | Comments

The most common type of hospital-associated infection may be preventable with a vaccine, new research in mice suggests. The experimental vaccine prevented urinary tract infections associated with catheters. Read more...          

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading